Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00476801 · ClinicalTrials.gov registry record · NA
UVA1 Light for Treatment of Scleroderma and Similar Conditions
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00476801 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 27 participants.
The verdict
NCT00476801, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this investigation is to evaluate the effectiveness of an investigational device which is similar in appearance to a "tanning bed" but which emits ultraviolet irradiation of a specific wavelength known as UVA1. This device has not been approved by the FDA for general use in this country, as yet, but it has been used quite successfully in Europe for several years in treating such conditions as scleroderma, keloids, and other fibrosing conditions of the skin. Your participation in this study may yield important information regarding the safety and effectiveness of this form of light therapy for the treatment of these skin conditions which, at present, are difficult to treat.
Interventions
- DEVICE German manufactured UVA1 light emitting device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2001-07 |
| Est. Completion | 2004-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00476801
The ClinicalTrials.gov registry entry for NCT00476801 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which German manufactured UVA1 light emitting device is the first listed.
NCT00476801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00476801 about?
NCT00476801 is a clinical study titled "UVA1 Light for Treatment of Scleroderma and Similar Conditions". The purpose of this investigation is to evaluate the effectiveness of an investigational device which is similar in appearance to a "tanning bed" but which emits ultraviolet irradiation of a specific wavelength known as UVA1. This device has not been approved by the FDA for general use in this count...
What is the current status of trial NCT00476801?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2001-07. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00476801?
The interventions under investigation include: German manufactured UVA1 light emitting device (DEVICE).
Who is sponsoring clinical trial NCT00476801?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.